Evidence map›Paper›PMID 27022626›Full record

ArticleeNeuro

Optogenetic Silencing of Nav1.8-Positive Afferents Alleviates Inflammatory and Neuropathic Pain.

Ihab Daou, Hélène Beaudry, Ariel R Ase, Jeffrey S Wieskopf, Alfredo Ribeiro-da-Silva, Jeffrey S Mogil, Philippe Séguéla

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 119 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Optogenetic and Chemogenic Control of Pain Signaling: Molecular Markers.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Review
  20. Peripheral mechanisms of peripheral neuropathic pain.Frontiers in molecular neuroscience · 2023
    Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ihab DaouDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada; The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada.
Hélène BeaudryDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada; The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.
Ariel R AseDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada; The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada.
Jeffrey S WieskopfThe Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada; Department of Psychology, McGill University, Montreal, Quebec H3A 1B1, Canada.
Alfredo Ribeiro-da-SilvaThe Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.
Jeffrey S MogilThe Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada; Department of Psychology, McGill University, Montreal, Quebec H3A 1B1, Canada.
Philippe SéguélaDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec H3A 2B4, Canada; The Alan Edwards Centre for Research on Pain, Montreal, Quebec H3A 0G1, Canada.
Edwards (United Kingdom) · GBMontreal Neurological Institute and Hospital · CAMcGill University · CA

Funding

Canadian Institutes of Health Research MOP-130239
6 · The paper itself

Abstract

We report a novel transgenic mouse model in which the terminals of peripheral nociceptors can be silenced optogenetically with high spatiotemporal precision, leading to the alleviation of inflammatory and neuropathic pain. Inhibitory archaerhodopsin-3 (Arch) proton pumps were delivered to Nav1.8(+) primary afferents using the Nav1.8-Cre driver line. Arch expression covered both peptidergic and nonpeptidergic nociceptors and yellow light stimulation reliably blocked electrically induced action potentials in DRG neurons. Acute transdermal illumination of the hindpaws of Nav1.8-Arch(+) mice significantly reduced mechanical allodynia under inflammatory conditions, while basal mechanical sensitivity was not affected by the optical stimulation. Arch-driven hyperpolarization of nociceptive terminals was sufficient to prevent channelrhodopsin-2 (ChR2)-mediated mechanical and thermal hypersensitivity in double-transgenic Nav1.8-ChR2(+)-Arch(+) mice. Furthermore, prolonged optical silencing of peripheral afferents in anesthetized Nav1.8-Arch(+) mice led to poststimulation analgesia with a significant decrease in mechanical and thermal hypersensitivity under inflammatory and neuropathic conditions. These findings highlight the role of peripheral neuronal inputs in the onset and maintenance of pain hypersensitivity, demonstrate the plasticity of pain pathways even after sensitization has occurred, and support the involvement of Nav1.8(+) afferents in both inflammatory and neuropathic pain. Together, we present a selective analgesic approach in which genetically identified subsets of peripheral sensory fibers can be remotely and optically inhibited with high temporal resolution, overcoming the compensatory limitations of genetic ablations.

Indexed as

Disease Models, AnimalAction PotentialsAnalgesiaAnimalsArchaeal ProteinsFemaleGanglia, SpinalHindlimbInflammationMaleMiceMice, Inbred C57BLMice, TransgenicNAV1.8 Voltage-Gated Sodium ChannelNeuralgiaNeural PathwaysArchaeal ProteinsNAV1.8 Voltage-Gated Sodium ChannelScn10a protein, mouseallodyniadorsal root gangliainflammationneuropathyoptogeneticsspinal cord

Identifiers

PMID27022626
PMCPMC4794527
OpenAlexW2288922397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.